Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOBI003 in Pediatric MPS IIIA Patients
NCT03423186Phase 2Completed
- Sponsor
- Sobi
- Start
- Jun 2018
- Primary completion
- Oct 2019
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of SOBI-003 in mucopolysaccharidosis type III A, sponsored by Sobi. Started Jun 2018; status: completed.
02
Drugs
SOBI-003
03
Conditions
mucopolysaccharidosis type III A
Beyond the preview
Go deeper on NCT03423186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423186.